BetaBlue is an early stage biopharmaceutical company seeking to commercialize functionally selective ligands for the D2 dopamine receptor with the goal of improved efficacy in treating the negative and cognitive symptoms of schizophrenia. We are also pursuing development for dyskinesia & dystonia, substance use disorders, and Huntington's disease.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- beta-blue.com
Betablue Questions
Betablue's website is beta-blue.com
Betablue's LinkedIn profile is https://www.linkedin.com/company/betablue
Betablue has
1 employees.
View email and phone details for 1
employees at Betablue.
Betablue's industry is
Pharmaceutical Manufacturing
Betablue's top competitors are
Bask,
Bettablue Digital,
Opko Health, Inc.,
Itolerance, Inc.,
Virtus Imaging Partners,
Schaeffler,
Biotissue,
Steris Endoscopy,
Lupin Pharmaceuticals,
Biedermann Motech.
Betablue's categories are Pharmaceutical Manufacturing
Betablue's founding year is 2016
